AHR and cancer: Generally, IDO1 signaling foster a tumor immunological microenvironment that is defective in recognizing and eradicating cancer cells by depleting Trp to generate Kyn, which in turn upregulates the immune‐tolerant cells levels within tumor tissues via activating AhR pathway.